Cabaletta Bio
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Cabaletta Bio and other ETFs, options, and stocks.About CABA
Cabaletta Bio, Inc. is a clinical-stage biotechnology company, which engages in the discovery and development of engineered T cell therapies for B cell-mediated autoimmune diseases. Its proprietary technology utilizes chimeric autoantibody receptor to selectively bind and eliminate B cells that produce disease-causing autoantibodies.
CEOSteven Nichtberger
CEOSteven Nichtberger
Employees161
Employees161
HeadquartersPhiladelphia, Pennsylvania
HeadquartersPhiladelphia, Pennsylvania
Founded2017
Founded2017
Employees161
Employees161
CABA Key Statistics
Market cap91.59M
Market cap91.59M
Price-Earnings ratio-0.78
Price-Earnings ratio-0.78
Dividend yield—
Dividend yield—
Average volume1.91M
Average volume1.91M
High today$2.93
High today$2.93
Low today$1.30
Low today$1.30
Open price$1.39
Open price$1.39
Volume13.06M
Volume13.06M
52 Week high$13.50
52 Week high$13.50
52 Week low$0.9857
52 Week low$0.9857
Analyst ratings
80%
of 10 ratingsBuy
80%
Hold
20%
Sell
0%
People also own
Based on the portfolios of people who own CABA. This list is generated using Robinhood data, and it’s not a recommendation.